FdaApplication
BLA 125694
Identifiers
- fda_app_no: BLA125694
Properties
| Property | Value |
|---|---|
| applicant_name | Novartis Gene Therapies, Inc. |
| application_type | BLA |
| approval_date | 2019-05-24 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ZOLGENSMA | — | 2x10^13VG/ML | Injection |
1 product